Omada Health to Participate in Goldman Sachs Global Healthcare Conference
Rhea-AI Summary
Omada Health (Nasdaq: OMDA) announced that senior management will participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026 in Miami. The appearance includes a fireside chat on Wednesday, June 10, at 8:20 a.m. PST, with a live webcast and replay available online.
Positive
- None.
Negative
- None.
News Market Reaction – OMDA
In the May 27 session, OMDA gained 2.24%, reflecting a moderate positive market reaction. Our momentum scanner triggered 5 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 07 | Access pathway expansion | Positive | -9.6% | Joined Lilly Employer Connect to expand GLP-1 Care Track employer access. |
| May 07 | Earnings results | Positive | -9.6% | Reported strong Q1 2026 growth, higher revenue, and narrower net loss. |
| Apr 17 | Clinical study data | Positive | +5.8% | 12-week GLP-1 study showed better weight, fat loss, and mental health. |
| Apr 16 | Earnings call scheduling | Neutral | +1.9% | Announced date and webcast details for Q1 2026 results call. |
| Mar 05 | Program launch | Positive | +3.3% | Launched GLP-1 Flex Care program offering flexible employer obesity support. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent fundamentally positive and partnership-focused news often saw mixed or negative next-day reactions, indicating a tendency for divergence between news tone and short-term price moves.
Over the last few months, Omada reported strong Q1 2026 growth, with higher revenue and members and improving profitability, alongside expanded GLP-1 programs like GLP-1 Flex Care and new pathways via Lilly’s Employer Connect. A positive 12-week GLP-1 study supported efficacy and mental health benefits. Despite these constructive updates, several events around March–May 2026 were followed by negative price reactions, making this conference participation part of an already active news flow.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN FRANCISCO, May 27, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026, taking place in Miami, including a fireside chat on Wednesday, June 10, at 8:20 a.m. PST. The webcast will be available online at https://investors.omadahealth.com/news-events/events. A replay will also be available at the same link following the event.
About Omada Health
Omada Health (Nasdaq: OMDA) is reverse engineering the way healthcare is delivered in America, putting the space between doctor visits–where health is won or lost–at the center of care. Today's healthcare system poorly serves chronic conditions that require ongoing support outside of the exam room, like obesity, diabetes, hypertension, cholesterol, and musculoskeletal conditions. Omada’s virtual-first model combines human-led care teams, connected devices, and AI-enabled technology to deliver personalized care at scale, including support for GLP-1 therapy. Omada has served more than two million members since launch across 2,000+ employers, health plans, pharmacy benefit managers, and health systems. Learn more at omadahealth.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. In some cases, forward-looking statements can be identified by words such as: “anticipate,” “intend,” “plan,” “believe,” “project,” “estimate,” “expect,” “may,” “should,” “will” and similar references to future periods.
Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, macroeconomic and industry conditions and other factors. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, but are not limited to, the following: our limited operating history and ability to manage our growth effectively; our history of net losses and ability to maintain profitability; the ability of our programs to achieve and maintain market acceptance; changes in the healthcare industry and competition; the growth and success of our customers and channel partners; the number of individuals covered by our programs and the number of our programs covered by our customers; the level of member engagement in our programs; our ability to maintain and grow customer and channel partner relationships; concentration of a substantial portion of our sales among a limited number of customers and channel partners; our ability to attract new customers and channel partners and increase member enrollment from existing and new customers and channel partners; our ability to increase the size of our organization; our dependence on a limited number of third-party suppliers; the impact of seasonality on our financial results; our ability to achieve widespread brand awareness and the impact of any negative media coverage; our ability to develop and release new programs and services; cybersecurity threats; our dependence on the interoperability of our programs and connected devices with third-party devices, operating systems and applications; changes in laws or regulations or the implementation of existing laws and regulations; compliance with privacy and security laws and regulations; our and our affiliated professional entities’ compliance with healthcare regulatory laws; any modification in U.S. Food and Drug Administration enforcement policies; our dependence on our relationships with affiliated professional entities; and other risk factors identified in our filings with the Securities and Exchange Commission (the “SEC”), including our most recent Quarterly Report on Form 10-Q for the quarter ended March 31, 2026.
All forward-looking statements in this press release are based only on information currently available to us and speak only as of the date on which they are made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise, except as required under applicable law.
Contacts
Craig Gracey
IR@omadahealth.com
Rose Ramseth
press@omadahealth.com
